Skip to content

    Anticoagulation in Intracerebral Hemorrhage

    Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery (ASPIRE): A StrokeNet Study

    This study is a randomized, double-blinded, phase III clinical trial designed to test the efficacy and safety of anticoagulation, compared with aspirin, in patients with a recent ICH and high-risk non-valvular atrial fibrillation/flutter (AF).

    Project Type: Research

    Year started: 2021

    Diagnosis: Stroke